Everything below concerns melanocortin analogue. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-03-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
Bremelanotide acts as an agonist at several melanocortin receptors, with the strongest reported activity at MC4R and measurable activity at MC1R and MC3R. Because MC4R is expressed in hypothalamic and limbic circuits, the proposed mechanism links receptor activation to modulation of central pathways involved in desire rather than to direct effects on peripheral genital tissue. The precise downstream steps remain incompletely characterized, and evidence for the involvement of specific neurotransmitters is suggestive rather than settled. Nausea and blood pressure elevation reported during trials are consistent with melanocortin signaling outside the intended target circuit.
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
Reverse-phase high-performance liquid chromatography is the standard method for assessing purity. Mass spectrometry confirms molecular identity and detects sequence variants or truncation products. Ultraviolet absorbance at 214 or 280 nm is used for quantification, with the choice depending on the peptide sequence. Method validation typically addresses linearity, limit of detection, and precision across a defined concentration range. Impurity profiling may also employ ion-exchange or size-exclusion chromatography, and these techniques complement one another.
Certificate of analysis documents usually report purity percentage, molecular weight, and appearance. Researchers verify identity by comparing observed and theoretical mass values. Chain-of-custody records and batch numbers help trace material from source to experiment. Independent verification of supplier claims is considered good practice when material identity is critical to a study. Records should include the storage history of each aliquot, and unexpected deviations in appearance or solubility warrant re-testing before use.
Lyophilized peptide material is generally stored at -20 °C or below to limit degradation, while reconstituted solutions are less stable and are typically kept refrigerated and protected from light. Repeated freeze-thaw cycles can accelerate aggregation and should be minimized. Stability for any specific lot depends on purity, moisture content, and packaging. Handling in a temperature-controlled environment reduces variability across replicates, and exposure to ambient humidity during weighing can introduce error. Aliquotting reduces the number of times a stock container is opened.
| Property | Value | Notes |
|---|---|---|
| Primary receptor target | MC4R | Highest reported agonist potency within the family |
| Secondary receptor activity | MC1R and MC3R | Lower potency than at MC4R |
| Elimination half-life | About 2 to 3 hours | Measured after subcutaneous administration |
| Plasma protein binding | Approximately 44 percent | Species- and assay-dependent |
| Route of administration | Subcutaneous injection | Reviewed product uses a single-use device |
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
Lyophilized peptide arrives as a white to off-white cake or powder and is normally held at minus twenty degrees Celsius or colder for extended periods. Short-term bench work at ambient temperature is tolerable for minutes, not hours, because the solid is hygroscopic and picks up moisture that promotes hydrolysis. Vials should stay in a desiccator or a sealed bag with desiccant, protected from light, since aromatic residues in the sequence are susceptible to photo-oxidation. Inventory records that note arrival date and storage location reduce the chance of using degraded material.
Reconstitution is usually performed with sterile water or a dilute acetic acid solution, and the choice of solvent affects both dissolution speed and final pH. Complete dissolution should be confirmed by visual inspection before any aliquot is taken, since undissolved particles can concentrate in the sampling volume. Repeated freeze-thaw cycles are the most common cause of gradual loss of purity, so dividing a stock into single-use aliquots at the first opportunity is standard practice. Working solutions kept refrigerated are generally used within days rather than weeks.
Approved use is narrow and jurisdiction-specific. In the United States, the injectable product is authorised for premenopausal women with acquired, generalised hypoactive sexual desire disorder, a diagnosis that requires documented distress. It is not approved for men, for postmenopausal women, or for use alongside hormonal contraceptives under the approved labelling. Outside regulated markets, the same peptide is frequently sold as a research chemical, where identity, purity, and sterility are not independently verified.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
Classically, MRONJ will cause an ulcer or areas of necrotic bone for weeks, months, or even years following a tooth extraction. While the exposed, dead bone does not cause symptoms these areas often have mild pain from the inflammation of the surrounding tissues. Clinical signs and symptoms associated with, but not limited to MRONJ, include:
== Safety and regulation == Active packaging is designed to interact with the packaged product or the surrounding environment. The active function does not remove the requirement for the underlying packaging to comply with applicable food-contact, pharmaceutical, transport, environmental, and product-safety rules. In the European Union, Commission Regulation (EC) No 450/2009 establishes specific requirements for active and intelligent materials intended to come into contact with food. It defines active materials as materials designed to deliberately release or absorb substances in order to extend shelf life or maintain or improve food condition. Substances intended to migrate into food may also be subject to food-additive and labelling requirements. Components positioned behind a functional barrier must remain within applicable migration limits. Intelligent packaging must not provide misleading information about the condition or safety of a product. An indicator that makes spoiled food appear acceptable could create a safety risk. Safety assessment may include:
Quinoa – first grown and cultivated in the Andes. This is a food grain which the indigenous Americans first developed and the grain is considered to be one of the most nutritious items there is. Quinine – a muscle relaxant, which has been used for many centuries by the Quechua people in the Andes area of South America. The medicine was used by many Andean people to prevent shivering due to cold in the low-temperature areas in the high Andes mountains of Peru. The ancient Peruvians would mix the ground bark of cinchona trees with water to eliminate the bark's bitter taste, and then drink the resultant tonic water to soothe their nerves and senses. Quipu – quipus were developed by the ancient Andeans. Quipus mimic an accounting, record-keeping, and communication system that uses knots and strings in order to record valuable information related to population, economic data, food grain supplies, calendars, events, etc. Qulliq – A crescent-shaped soapstone oil lamp fuelled by rendered seal blubber with a wick of dried Arctic cottongrass or moss, used by the Inuit and other circumpolar peoples for heating, lighting, cooking, melting snow, and drying clothes in the Arctic environment. Oil lamps have been found at Paleo-Eskimo sites dating to the Norton tradition approximately 3,000 years ago and were a standard implement of the Dorset culture and the Thule people, showing little design change over millennia. The qulliq was the single most important piece of household equipment in Inuit dwellings, tended by women and carried with the family when they moved.
== Recent writing == Recent articles about insulin coma treatment have attempted to explain why it was given such uncritical acceptance. In the US, Deborah Doroshow wrote that insulin coma therapy secured its foothold in psychiatry not because of scientific evidence or knowledge of any mechanism of therapeutic action, but due to the impressions it made on the minds of the medical practitioners within the local world in which it was administered and the dramatic recoveries observed in some patients. Today, she writes, those who were involved are often ashamed, recalling it as unscientific and inhumane. Administering insulin coma therapy made psychiatry seem a more legitimate medical field. Harold Bourne, who questioned the treatment at the time, said: "It meant that psychiatrists had something to do. It made them feel like real doctors instead of just institutional attendants". One retired psychiatrist who was interviewed by Doroshow "described being won over because his patients were so sick and alternative treatments did not exist". Doroshow argues that "psychiatrists used complications to exert their practical and intellectual expertise in a hospital setting" and that collective risk-taking established "especially tight bonds among unit staff members". She finds it ironic that psychiatrists "who were willing to take large therapeutic risks were extremely careful in their handling of adverse effects".
Sources: en.wikipedia.org
=== Brand names === Dutasteride is sold primarily under the brand name Avodart, but also in combination with tamsulosin under the brand names Combodart, Duodart, and Jalyn. Dutasteride is also available in India in combination with alfuzosin under the brand names Alfusin-D and Dutalfa.
At a meeting of the Pheu Thai Party on 20 March 2022, Paetongtarn was elected as "Head of the Pheu Thai Family". When speaking at the Pheu Thai Party's annual general meeting in April 2022, she said that she wanted to see regime change in Thailand and wanted to gain more experience before standing for the post of the country's prime minister. Paetongtarn became the leading prime minister-candidate in the opinion polls. In April 2023, she was officially nominated as one of the three prime minister-candidates of Pheu Thai Party for the general election, along with Srettha Thavisin and Chaikasem Nitisiri. After the general election in May 2023, the Pheu Thai Party secured the second-highest number of seats in the House of Representatives, following the Move Forward Party. She expressed disappointment that the party did not achieve first place as planned but stated that she was ready to work with the Move Forward Party and other parties willing to form a coalition with both parties. However, after Pheu Thai Party withdrew from the memorandum of understanding to form a government with the Move Forward Party, on 9 August, she and Pheu Thai Party executives walked from the OAI Tower, where the party's headquarters are located, to the neighbouring Thai Summit Tower to discuss with the Move Forward Party leaders about endorsing a candidate for the third round of prime ministerial voting.
In 1986, due to low prostaglandin H2 product purity from thin-layer chromatography and column chromatography, high-performance liquid chromatography with hexane and isopropanol as solvents was developed as an alternative means of isolating the prostaglandin with 98% purity.
AOA1 is caused by biallelic mutation in APTX gene. Missense mutations (mutations that result in the change of amino acids in the specific location of the protein) usually result in much milder symptoms and delayed onset than truncating mutations. Founder effect was found in Japanese and Portuguese patients (V230fs and P206L are Japanese founder mutations; R199H and W279X are Portuguese founder mutations). Monoallelic variants, in rare cases, can produce phenotype similar to multiple system atrophy.
== External links == Legio X – Legio X Gemina (Equites) – "Viri Clarissimi" Livius.org: List of Roman legions Archived 2014-06-26 at the Wayback Machine A catalogue of Roman legions Legio V Living History Group in Tennessee Roman legions from Dacia (KML file) Archived 2012-01-20 at the Wayback Machine
Sources: en.wikipedia.org
Reported activity is highest at MC4R, with lower potency at MC1R and MC3R. The MC4R interaction is generally treated as the most relevant to its central effects. Selectivity is not absolute, and activity across the family is dose-dependent.
Indirect evidence from animal studies supports central access, and the proposed mechanism requires it. Direct quantification in humans is limited. How much reaches specific brain regions remains an open question.
Published descriptions give a plasma half-life of roughly two to three hours after subcutaneous administration. Values vary with assay method and study population. The figure is an average rather than a fixed molecular property.
Storage at -20 °C or below is standard for long-term stability. Desiccant and sealed containers limit moisture exposure. Solutions are prepared only when needed.